12:00 AM
 | 
Jul 27, 2015
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Lorediplon: Phase IIa started

Ferrer began a double-blind, placebo-controlled, crossover, international Phase IIa trial to compare 5 and 10 mg oral Lorediplon vs. zolpidem in about 130 adult insomniacs. Ferrer is conducting the trial in collaboration with CRO Ergomed and...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >